Saturday, February 11, 2012
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Research & Development
1 of 5
Previous |
Next
Research & Development
Self or non-self
Detecting and characterizing wanted and unwanted immune responses to new biopharmaceuticals is an essential task in order to ensure clinical safety and efficacy. An outline by Eurofins Medinet
No Comments
Making the vital connection
NGP talks to GSK's Paul Matthews about the unique challenges posed by the combination of imaging and drug development.
No Comments
Fixing the failure rate
Celgene Corporation’s Kamal Shah looks at why most new drug compounds fail to progress beyond the clinical trial stage.
No Comments
Patient-centric commercialisation
Justin van Gennep of Quintiles explains how alternative models for healthcare delivery will improve patient compliance and provide valuable, real-world outcomes data.
No Comments
The perfect storm
Quintiles' John Hall tells NGP of the burning issues in the biopharmaceutical industry.
No Comments
1 of 5
Previous |
Next
Source: www.ngpharma.eu.com© 2012 GDS Publishing Ltd. All rights reserved.